Unravelling Fibromyalgia—Steps Toward Individualized Management

Ablin, 2013, Guidelines for the diagnosis and treatment of the fibromyalgia syndrome [in Hebrew], Harefuah, 152, 742 Alciati, 2012, Psychiatric problems in fibromyalgia: Clinical and neurobiological links between mood disorders and fibromyalgia, Reumatismo, 64, 268, 10.4081/reumatismo.2012.268 Arnold, 2016, Fibromyalgia and chronic pain syndromes: A white paper detailing current challenges in the field, Clin J Pain, 32, 737, 10.1097/AJP.0000000000000354 Arnold, 2009, Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder, Clin J Pain, 25, 461, 10.1097/AJP.0b013e318197d4e4 Arnold, 2015, Efficacy and safety of pregabalin in patients with fibromyalgia and comorbid depression taking concurrent antidepressant medication: A randomized, placebo-controlled study, J Rheumatol, 42, 1237, 10.3899/jrheum.141196 Barnett, 2012, Epidemiology of multimorbidity and implications for health care, research, and medical education: A cross-sectional study, Lancet, 380, 37, 10.1016/S0140-6736(12)60240-2 Bennett, 2005, The Fibromyalgia Impact Questionnaire (FIQ): A review of its development, current version, operating characteristics and uses, Clin Exp Rheumatol, 23, S154 Benor, 2017, A Randomized, controlled trial of wholistic hybrid derived from eye movement desensitization and reprocessing and emotional freedom technique (WHEE) for self-treatment of pain, depression, and anxiety in chronic pain patients, J Evid Based Complementary Altern Med, 10.1177/2156587216659400 Bernardy, 2017, Efficacy, acceptability and safety of cognitive behavioural therapies in fibromyalgia syndrome – A systematic review and meta-analysis of randomized controlled trials, Eur J Pain Boomershine, 2011, Simplifying fibromyalgia assessment: The VASFIQ brief symptom scale, Ther Adv Musculoskelet Dis, 3, 215, 10.1177/1759720X11416863 Chronic Pain Research Alliance Clauw, 2014, Fibromyalgia: A clinical review, JAMA, 311, 1547, 10.1001/jama.2014.3266 Derry, 2016, Pregabalin for pain in fibromyalgia in adults, Cochrane Database Syst Rev Docampo, 2013, Cluster analysis of clinical data identifies fibromyalgia subgroups, PloS One, 8, e74873, 10.1371/journal.pone.0074873 Eich, 2017, Definition, classification, clinical diagnosis and prognosis of fibromyalgia syndrome : Updated guidelines 2017 and overview of systematic review articles, Schmerz Fairburn, 2014, The global dissemination of psychological treatments: A road map for research and practice, Am J Psychiatry, 171, 495, 10.1176/appi.ajp.2013.13111546 Fitzcharles, 2013, Canadian guidelines for the diagnosis and management of fibromyalgia syndrome: Executive summary, Pain Res Manag, 18, 119, 10.1155/2013/918216 Forte Glombiewski, 2013, Efficacy of EMG- and EEG-biofeedback in fibromyalgia syndrome: A meta-analysis and a systematic review of randomized controlled trials, Evid Based Complement Alternat Med, 2013, 962741, 10.1155/2013/962741 Häuser, 2015, Fibromyalgia, Nat Rev Dis Primers, 1, 15022, 10.1038/nrdp.2015.22 Häuser, 2013, Posttraumatic stress disorder in fibromyalgia syndrome: Prevalence, temporal relationship between posttraumatic stress and fibromyalgia symptoms, and impact on clinical outcome, Pain, 154, 1216, 10.1016/j.pain.2013.03.034 Häuser, 2014, Patient health questionnaire 15 as a generic measure of severity in fibromyalgia syndrome: Surveys with patients of three different settings, J Psychosom Res, 76, 307, 10.1016/j.jpsychores.2014.01.009 Häuser, 2013, Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome, Cochrane Database Syst Rev Henningsen, 2007, Management of functional somatic syndromes, Lancet, 369, 946, 10.1016/S0140-6736(07)60159-7 Jessup, 2016, 2016 ESC and ACC/AHA/HFSA heart failure guideline update—what is new and why is it important?, Nat Rev Cardiol, 13, 623, 10.1038/nrcardio.2016.134 Jiao, 2015, Association of rheumatic diseases with symptom severity, quality of life, and treatment outcome in patients with fibromyalgia, Scand J Rheumatol, 1, 1 Jiao, 2015, Association of abuse history with symptom severity and quality of life in patients with fibromyalgia, Rheumatol Int, 35, 547, 10.1007/s00296-014-3113-0 Jones, 2006, A comprehensive review of 46 exercise treatment studies in fibromyalgia (1988–2005), Health Qual Life Outcomes, 4, 67, 10.1186/1477-7525-4-67 Lage-Hansen, 2015, Concomitant fibromyalgia in rheumatoid arthritis is associated with the more frequent use of biological therapy: A cross-sectional study, Scand J Rheumatolm, 1, 1 Lange, 2010, Influence of depression on fibromyalgia: A systematic review, Schmerz, 24, 326, 10.1007/s00482-010-0937-8 Lipkovich, 2014 Lubrano, 2001, Fibromyalgia in patients with irritable bowel syndrome. An association with the severity of the intestinal disorder, Int J Colorectal Dis, 16, 211, 10.1007/s003840100299 Lumley, 2017, Emotional awareness and expression therapy, cognitive behavioral therapy, and education for fibromyalgia: a cluster-randomized controlled trial, Pain, 10.1097/j.pain.0000000000001036 Macfarlane, 2017, EULAR revised recommendations for the management of fibromyalgia, Ann Rheum Dis, 76, 318, 10.1136/annrheumdis-2016-209724 Mansfield, 2017, Identifying patients with chronic widespread pain in primary care, Pain, 158, 110, 10.1097/j.pain.0000000000000733 Martínez-Martínez, 2014, Sympathetic nervous system dysfunction in fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, and interstitial cystitis: A review of case-control studies, J Clin Rheumatol, 20, 146, 10.1097/RHU.0000000000000089 Murakami, 2015, A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients, Arthritis Res Ther, 17, 224, 10.1186/s13075-015-0718-y Naeem, 2015, Using cognitive behaviour therapy with South Asian Muslims: Findings from the culturally sensitive CBT project, Int Rev Psychiatry, 27, 233 Pauer, 2011, An international, randomized, double-blind, placebo controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia, J Rheumatol, 38, 2643, 10.3899/jrheum.110569 Perrot, 2014, More ubiquitous effects from non-pharmacologic than from pharmacologic treatments for fibromyalgia syndrome: A meta-analysis examining six core symptoms, Eur J Pain, 18, 1067, 10.1002/ejp.564 Perrot, 2012, Societal and individual burden of illness among fibromyalgia patients in France: Association between disease severity and OMERACT core domains, BMC Musculoskelet Disord, 13, 22, 10.1186/1471-2474-13-22 Petzke, 2017, General treatment principles, coordination of care and patient education in fibromyalgia syndrome : Updated guidelines 2017 and overview of systematic review articles [in German], Schmerz, 31, 246, 10.1007/s00482-017-0201-6 Przekop, 2012, Self-reported physical health, mental health, and comorbid diseases among women with irritable bowel syndrome, fibromyalgia, or both compared with healthy control respondents, J Am Osteopath Assoc, 112, 726 Ranzolin, 2009, Association of concomitant fibromyalgia with worse disease activity score in 28 joints, health assessment questionnaire, and short form 36 scores in patients with rheumatoid arthritis, Arthritis Rheum, 61, 794, 10.1002/art.24430 Rehm, 2010, A cross-sectional survey of 3035 patients with fibromyalgia: Subgroups of patients with typical comorbidities and sensory symptom profiles, Rheumatology (Oxford), 49, 1146, 10.1093/rheumatology/keq066 Rivera, 2014, Classifying fibromyalgia patients according to severity: The combined index of severity in fibromyalgia, Rheumatol Int, 34, 1683, 10.1007/s00296-014-3029-8 Schaefer, 2011, The comparative burden of mild, moderate and severe fibromyalgia: Results from a cross-sectional survey in the United States, Health Qual Life Outcomes, 9, 71, 10.1186/1477-7525-9-71 Thieme, 2017, Evidenced-based guidelines on the treatment of fibromyalgia patients: Are they consistent and if not, why not? Have effective psychological treatments been overlooked?, J Pain, 18, 747, 10.1016/j.jpain.2016.12.006 Thieme, 2015, The relationship among psychological and psychophysiological characteristics of fibromyalgia patients, J Pain, 16, 186, 10.1016/j.jpain.2014.11.009 Torres, 2013, Personality does not distinguish people with fibromyalgia but identifies subgroups of patients, Gen Hosp Psychiatry, 35, 640, 10.1016/j.genhosppsych.2013.07.014 Toussaint, 2017, Post-traumatic stress disorder symptoms may explain poor mental health in patients with fibromyalgia, J Health Psychol, 22, 697, 10.1177/1359105315611957 Turk, 1998, Differential responses by psychosocial subgroups of fibromyalgia syndrome patients to an interdisciplinary treatment, Arthritis Care Res, 11, 397, 10.1002/art.1790110511 Üçeyler, 2017, Etiology and pathophysiology of fibromyalgia syndrome : Updated guidelines 2017, overview of systematic review articles and overview of studies on small fiber neuropathy in FMS subgroups [in German], Schmerz, 31, 239, 10.1007/s00482-017-0202-5 Üçeyler, 2011, Systematic review with meta-analysis: Cytokines in fibromyalgia syndrome, BMC Musculoskelet Disord, 12, 245, 10.1186/1471-2474-12-245 Üçeyler, 2013, Anticonvulsants for fibromyalgia, Cochrane Database Syst Rev, 10.1002/14651858.CD010782 van Koulil, 2010, Tailored cognitive-behavioral therapy and exercise training for high-risk patients with fibromyalgia, Arthritis Care Res (Hoboken), 62, 1377, 10.1002/acr.20268 Vincent, 2014, OMERACT-based fibromyalgia symptom subgroups: An exploratory cluster analysis, Arthritis Res Ther, 16, 463, 10.1186/s13075-014-0463-7 Vitiello, 2014, Short-term improvement in insomnia symptoms predicts long-term improvements in sleep, pain, and fatigue in older adults with comorbid osteoarthritis and insomnia, Pain, 155, 1547, 10.1016/j.pain.2014.04.032 Wilson, 2009, Toward the identification of symptom patterns in people with fibromyalgia, Arthritis Rheum, 61, 527, 10.1002/art.24163 Wolfe, 2016, 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria, Semin Arthritis Rheum, 46, 319, 10.1016/j.semarthrit.2016.08.012 Wolfe, 2011, Fibromyalgia criteria and severity scales for clinical and epidemiological studies: A modification of the ACR preliminary diagnostic criteria for fibromyalgia, J Rheumatol, 38, 1113, 10.3899/jrheum.100594 Wolfe, 2010, The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity, Arthritis Care Res (Hoboken), 62, 600, 10.1002/acr.20140 Wolfe, 2016, Comparison of physician-based and patient-based criteria for the diagnosis of fibromyalgia, Arthritis Care Res (Hoboken), 68, 652, 10.1002/acr.22742 Wolfe, 1990, The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee, Arthritis Rheum, 33, 160, 10.1002/art.1780330203 Wolfe, 2015, The use of polysymptomatic distress categories in the evaluation of fibromyalgia (FM) and FM severity, J Rheumatol, 42, 1494, 10.3899/jrheum.141519 Yunus, 2012, The prevalence of fibromyalgia in other chronic pain conditions, Pain Res Treat, 2012, 584573 Zech, 2017, Efficacy, tolerability and safety of guided imagery/hypnosis in fibromyalgia, Eur J Pain, 21, 217, 10.1002/ejp.933